| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1400118 | 重组抗TNFα全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-03-24 | 上海迈泰亚博生物技术有限公司 | Shanghai MabLab Biotechnology Co Ltd | Certificate Issued | 2016-09-03 | view |